Antonina Frolova

Medicine & Life Sciences

1. Amniotomy 28%
2. Anemia 31%
3. Blastocyst 27%
4. Cardiotocography 81%
5. Confidence Intervals 31%
6. Cumulus Cells 26%
7. Deceleration 33%
8. Dehydroepiandrosterone 44%
9. Embryo Implantation 52%
10. Estrogen Receptors 34%
11. Estrogens 34%
12. Facilitative Glucose Transport Proteins 58%
13. Fetal Distress 26%
14. Fetal Growth Retardation 31%
15. Glucose 39%
16. Glucose Transporter Type 1 28%
17. Growth 27%
18. Induced Labor 60%
19. Litter Size 32%
20. Meta-Analysis 41%
21. Morbidity 77%
22. Mothers 100%
23. Multi-Institutional Systems 32%
24. Neonatal Intensive Care Units 26%
25. Obesity 44%
26. Odds Ratio 49%
27. Oocytes 55%
28. Optical Devices 32%
29. Oxytocin 59%
30. Oxytocin Receptors 76%
31. Parturition 29%
32. Pentose Phosphate Pathway 53%
33. Polycystic Ovary Syndrome 32%
34. Postpartum Hemorrhage 85%
35. Pregnancy 80%
36. Pregnancy in Diabetics 29%
37. Pregnancy Outcome 37%
38. Randomized Controlled Trials 34%
39. Second Labor Stage 57%
40. Serum 26%
41. Sphingosine-1-Phosphate Receptors 25%
42. Stromal Cells 83%
43. Systematic Reviews 40%
44. Third Labor Stage 28%
45. Umbilical Arteries 78%
46. Unsaturated Fatty Acids 39%
47. Uterine Monitoring 31%
48. Uterus 36%
49. Venous Thromboembolism 31%
50. Wearable Electronic Devices 35%